Skip to main content
. 2012 May 18;3(2):179–197.

Table 2.

Cell cycle distribution after YM155 treatment.

Cell lines Treatment Cell cycle distribution (%)

Sub-G1 G1 S G2/M
PC3 DMSO(0.1%),24hrs 1.09 29.95 14.91 54.42
10nM YM155,24hrs 0.91 31.13 21.04 47.74
20nM YM155,24hrs 1.54 31.99 18.09 48.66
100nM YM155,24hrs 6.45 15.13 18.25 58.70
DMSO(0.1%),48hrs 0.54 42.13 12.67 45.09
5nM YM155,48hrs 0.85 43.35 13.38 42.64
10nM YM155,48hrs 1.18 33.92 17.57 47.81
20nM YM155,48hrs 4.02 18.53 19.40 57.38

EKVX DMSO(0.1%),24hrs 1.47 60.23 7.09 31.22
10nM YM155,24hrs 8.42 51.35 10.37 29.92
20nM YM155,24hrs 7.73 49.61 10.42 32.19
100nM YM155,24hrs 13.57 42.01 13.32 31.23
DMSO(0.1%),48hrs 1. 34 61.60 9.15 27.90
5nM YM155,48hrs 8.20 45.08 9.53 37.19
10nM YM155,48hrs 25.63 37.81 12.85 23.87
20nM YM155,48hrs 41.09 31.41 10.49 17.06